These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1479418)
1. Experimental studies of immunotoxicity of a photosensitizing agent (Photofrin II) in mice. Bianchi R; Giampietri A; Campanile F; Fioretti MC; Puccetti P J Chemother; 1992 Oct; 4(5):290-6. PubMed ID: 1479418 [TBL] [Abstract][Full Text] [Related]
2. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice. Smith DC; Smith MJ; White KL J Immunotoxicol; 2010; 7(3):219-31. PubMed ID: 20509767 [TBL] [Abstract][Full Text] [Related]
3. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction. Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect. Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of natural killer cell activity by anti-host delayed-type hypersensitivity during the graft-versus-host reaction in mice. Mowat AM; Borland A; Parrott DM Scand J Immunol; 1985 Oct; 22(4):389-99. PubMed ID: 4070976 [TBL] [Abstract][Full Text] [Related]
9. Effects of retinoic acid on the immune system: stimulation of T killer cell induction. Dennert G; Lotan R Eur J Immunol; 1978 Jan; 8(1):23-9. PubMed ID: 346357 [TBL] [Abstract][Full Text] [Related]
10. Local and systemic immune response to inactivated Candida albicans in mice. Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818 [TBL] [Abstract][Full Text] [Related]
11. Topical exposure to 2-butoxyethanol alters immune responses in female BALB/c mice. Singh P; Zhao S; Blaylock BL Int J Toxicol; 2001; 20(6):383-90. PubMed ID: 11797820 [TBL] [Abstract][Full Text] [Related]
12. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors. Fuyama S; Komatsu H; Arai S Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. Perez M; Edelson R; Laroche L; Berger C J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance. Dean JH; Ward EC; Murray MJ; Lauer LD; House RV; Stillman W; Hamilton TA; Adams DO Int J Immunopharmacol; 1986; 8(2):189-98. PubMed ID: 3086244 [TBL] [Abstract][Full Text] [Related]
15. Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice. Karrow NA; McCay JA; Brown R; Musgrove D; Munson AE; White KL Drug Chem Toxicol; 2000 Nov; 23(4):621-44. PubMed ID: 11071398 [TBL] [Abstract][Full Text] [Related]
16. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate. Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295 [TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease. Ghayur T; Seemayer TA; Kongshavn PA; Gartner JG; Lapp WS Transplantation; 1987 Aug; 44(2):261-7. PubMed ID: 3307050 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models. Vourka-Karussis U; Ackerstein A; Pugatsch T; Slavin S Exp Hematol; 1999 Mar; 27(3):461-9. PubMed ID: 10089908 [TBL] [Abstract][Full Text] [Related]
19. Immunopharmacological studies of ribavirin, a broad-spectrum antiviral agent. Borghi C; Allegrucci M; Ballerini P; Bianchi R; Puccetti P; Romani L; Fioretti MC Chemioterapia; 1987 Jun; 6(2 Suppl):660-3. PubMed ID: 3509519 [No Abstract] [Full Text] [Related]
20. The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells. Sykes M; Abraham VS Transplantation; 1992 May; 53(5):1063-70. PubMed ID: 1533968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]